Medicare drug coverage

XIFAXAN in Florida: 2027 Part D coverage

549 of 549 Part D plans offered in Florida (100%) list XIFAXAN on their 2027 formulary, the plan's list of covered drugs (the same share as 2026). 100% of those require prior authorization, step therapy, or a quantity limit. Plan counts include both Medicare Advantage plans with drug coverage (538 MA-PD) and stand-alone drug plans (11 PDP).

License: a US government work, in the public domain (Public Domain Mark 1.0).

For pharmacies and agencies: check a whole drug list against 2027 formularies.

Upload your patient list or your book of clients and Rivvi checks each drug against the CMS 2027 formulary files, plan by plan, so you see tier changes and new limits before the next refill or open enrollment. Free to start. HIPAA BAA included.

Every 2027 plan in Florida

Each Part D plan offered in Florida, with XIFAXAN's 2026 and 2027 tier and its 2027 limits. A tier is the cost level a plan puts a drug on; a lower tier usually costs less. Enter a ZIP to see only the plans offered in that county.

Runs on this page. No account, and the ZIP is not stored.

PA is prior authorization (the plan must approve it first), ST is step therapy (try another drug first), and QL is a quantity limit. D-SNP, C-SNP, and I-SNP are Special Needs Plans: for people with both Medicare and Medicaid, with certain chronic conditions, or who live in a nursing home or need that level of care. Plans are listed by plan ID.

XIFAXAN, 2027 Part D plans, in plan ID order
PlanPlan IDType2026 tier2027 tier2027 PA / ST / QLChange
UHC Nursing Home Plan EX-F001 (PPO I-SNP)H0710-004-000MA-PD (PPO I-SNP)Tier 4Tier 3PATier 4 to 3
UHC Nursing Home Plan FL-F001 (PPO I-SNP)H0710-010-000MA-PD (PPO I-SNP)Tier 4Tier 3PATier 4 to 3
UHC Nursing Home Plan FL-F002 (PPO I-SNP)H0710-038-000MA-PD (PPO I-SNP)Tier 4Tier 3PATier 4 to 3
Solis Guardian Plan (HMO D-SNP)H0982-002-000MA-PD (HMO D-SNP)Tier 5Tier 3PA, QLTier 5 to 3
Solis Healthy Living Plan (HMO)H0982-007-000MA-PD (HMO)Tier 5Tier 3PA, QLTier 5 to 3
Solis Healthy Living Plan (HMO)H0982-008-000MA-PD (HMO)Tier 5Tier 3PA, QLTier 5 to 3
Solis Healthy Living Plan (HMO)H0982-009-000MA-PD (HMO)Tier 5Tier 3PA, QLTier 5 to 3
Solis Guardian Plan (HMO D-SNP)H0982-010-000MA-PD (HMO D-SNP)Tier 5Tier 3PA, QLTier 5 to 3
Solis Guardian Plan (HMO D-SNP)H0982-012-000MA-PD (HMO D-SNP)Tier 5Tier 3PA, QLTier 5 to 3
Solis Guardian Plan (HMO D-SNP)H0982-013-000MA-PD (HMO D-SNP)Tier 5Tier 3PA, QLTier 5 to 3
Solis Wellness Plan (HMO C-SNP)H0982-016-000MA-PD (HMO C-SNP)Tier 5Tier 3PA, QLTier 5 to 3
Solis Wellness Plan (HMO C-SNP)H0982-017-000MA-PD (HMO C-SNP)Tier 5Tier 3PA, QLTier 5 to 3
Solis Healthy Living Plan (HMO)H0982-022-000MA-PD (HMO)Tier 5Tier 3PA, QLTier 5 to 3
Solis Healthy Living Plan (HMO)H0982-024-000MA-PD (HMO)Tier 5Tier 3PA, QLTier 5 to 3
Solis Guardian Plan (HMO D-SNP)H0982-025-000MA-PD (HMO D-SNP)Tier 5Tier 3PA, QLTier 5 to 3
Solis Wellness Plan (HMO C-SNP)H0982-026-000MA-PD (HMO C-SNP)Tier 5Tier 3PA, QLTier 5 to 3
Solis Balanced Plan (HMO C-SNP)H0982-027-000MA-PD (HMO C-SNP)Tier 5Tier 3PA, QLTier 5 to 3
Solis Wellness Giveback Plan (HMO C-SNP)H0982-028-000MA-PD (HMO C-SNP)Tier 5Tier 3PA, QLTier 5 to 3
Solis Wellness Giveback Plan (HMO C-SNP)H0982-030-000MA-PD (HMO C-SNP)Tier 5Tier 3PA, QLTier 5 to 3
Solis Wellness Giveback Plan (HMO C-SNP)H0982-031-000MA-PD (HMO C-SNP)Tier 5Tier 3PA, QLTier 5 to 3
Solis Wellness Giveback Plan (HMO C-SNP)H0982-033-000MA-PD (HMO C-SNP)Tier 5Tier 3PA, QLTier 5 to 3
Solis Balanced Plan (HMO C-SNP)H0982-034-000MA-PD (HMO C-SNP)New plan IDTier 3PA, QLNew plan ID in 2027
CareOne Plus (HMO-POS)H1019-001-000MA-PD (HMO-POS)Tier 4Tier 3PA, QLTier 4 to 3
CareOne Plus (HMO)H1019-006-000MA-PD (HMO)Tier 4Tier 3PA, QLTier 4 to 3
CareNeeds Platinum (HMO D-SNP)H1019-023-000MA-PD (HMO D-SNP)Tier 4Tier 3PA, QLTier 4 to 3

Data only, not plan advice. Confirm on Medicare.gov Plan Finder or 1-800-MEDICARE.

Florida compared with the nation

100% of the 549 Part D plans offered in Florida leave XIFAXAN off the 2027 formulary or restrict it, against 97% nationally (3 points higher). Florida is tied with 38 other states at 100% of plans restricting or leaving it off. A plan offered in several states counts in each.

XIFAXAN in every state and by parent organization

2027 compared with 2026

XIFAXAN Part D coverage, 2026 and 2027
Measure20262027Change
Part D plans in the file597549-48
Plans that list it597 (100%)549 (100%)no change
Prior authorization (of plans that list it)597 (100%)436 (79%)-21 points
Step therapy (of plans that list it)0 (0%)0 (0%)no change
Quantity limit (of plans that list it)349 (58%)486 (89%)+31 points
Any of the three (of plans that list it)597 (100%)549 (100%)no change
Not listed or restricted (of all plans)597 (100%)549 (100%)no change

Formulary tier

XIFAXAN formulary tier, 2026 and 2027
Tier2026 plans2027 plans
Tier 111 (2%)7 (1%)
Tier 20 (0%)63 (11%)
Tier 353 (9%)479 (87%)
Tier 4292 (49%)0 (0%)
Tier 5241 (40%)0 (0%)

Plan by plan, 2026 to 2027

XIFAXAN: plans in both 2026 and 2027
Plan by planPlans
Same plan ID in both years476
Listed it in 2026, not in 20270 (0%)
Listed it in 2027, not in 20260 (0%)
Moved it to a higher tier5 (1%)
Moved it to a lower tier460 (97%)
Added prior authorization0 (0%)
Added step therapy0 (0%)
Added a quantity limit157 (33%)
Added at least one of the three157 (33%)
Removed at least one of the three88 (18%)
Plan IDs new in 202773
2026 plan IDs not in the 2027 file121

The CMS summary has no count of tier moves down, so "Moved it to a lower tier" is counted from the plan rows on this page: plans with the same plan ID in both years that list XIFAXAN both years.

XIFAXAN in other states

About this data

A plan here is one Part D plan as the CMS formulary files list it: contract, plan, and segment. That covers Medicare Advantage plans with drug coverage and stand-alone drug plans. A plan lists a drug when its formulary has a row for any RxNorm product of that name. When it has several, the row with the lowest tier is the one counted, and restricted means that row has prior authorization, step therapy, or a quantity limit.

A plan with no row for the drug counts as not listing it. That can be a product the file codes another way, so read a low count as a lookup result, not a coverage decision. A state counts every plan the CMS landscape file offers there. Parent organizations are named as CMS names them. The drug list is the top 200 by total Part D spending.

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Source: CMS 2026 Part D formulary file (basic drugs and plan information), as of September 30, 2026. Publisher page

Source: CMS CY2027 landscape file (states and parent organizations), as of September 30, 2026. Publisher page

Source: CMS CY2026 landscape file, as of September 25, 2025. Publisher page

Source: CMS Medicare Part D Spending by Drug, 2024 data, as of June 25, 2026. Publisher page

Source: US Census Bureau 2020 ZCTA to county relationship file (ZIP lookup), as of December 9, 2021. Publisher page

Try it on your own data today.

Free to start. Most teams are using it the same day.